Czech Republic

The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent... 2010-03-11

BMI's expectation that the proposed 7% reductions in the Czech Republic's pricing and reimbursement scheme in January 2010 would cause maximum consumer prices to actually rise[1]... 2010-01-21

BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected... 2010-01-05

A&D Pharma Holdings, the owner of Romania's leading pharmaceutical wholesale, sales and marketing services and retail business, has confirmed the acquisition of privately held... 2009-12-29

Prospects for growth in the Czech Republic's US$4.2bn pharmaceutical market appear ominous for 2010, pending the resolution of challenges to pricing legislation proposed in late 2009.... 2009-12-16

BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings.... 2009-10-30

The role of the Czech Republic's State Institute for Drug Control (SÚKL) in collecting information about the prescribing and dispending of medicine has come under scrutiny, following... 2009-08-19

The opposition Social Democrats (CSSD)'s plans to undermine healthcare reforms in the Czech Republic look more plausible than ever, after a crushing defeat for the Civic Democratic... 2008-10-24

Pharmaceutical prices in the Czech Republic are set to significantly decline in late 2008/early 2009, as the implementation of pricing and reimbursement reforms will introduce a dual... 2008-09-25

Despite having been introduced over nine months ago, the controversy surrounding the Czech Republic's healthcare reforms - particularly patient fees - remains a key battlefield in... 2008-09-03